Variant report
Variant | esv3507847 |
---|---|
Chromosome Location | chr6:132114119-132118663 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117372007 | chr6:132114125-132114126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112601466 | chr6:132114127-132114128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562549309 | chr6:132114178-132114179 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529849653 | chr6:132114187-132114188 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142996482 | chr6:132114192-132114193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs3844009 | chr6:132114203-132114204 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs114203858 | chr6:132114205-132114206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143679306 | chr6:132114266-132114267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113347028 | chr6:132114272-132114273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148089018 | chr6:132114284-132114285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141867218 | chr6:132114317-132114318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150646622 | chr6:132114322-132114323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113402887 | chr6:132114341-132114342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181407917 | chr6:132114342-132114343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554851596 | chr6:132114363-132114364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573399357 | chr6:132114386-132114387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111757777 | chr6:132114454-132114455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559032171 | chr6:132114499-132114500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577267487 | chr6:132114521-132114522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12055633 | chr6:132114553-132114554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531559125 | chr6:132114601-132114602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544181517 | chr6:132114627-132114628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs59532822 | chr6:132114638-132114639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111557009 | chr6:132114646-132114647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112366007 | chr6:132114647-132114648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562772937 | chr6:132114671-132114672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6931816 | chr6:132114703-132114704 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs542041653 | chr6:132114759-132114760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113737656 | chr6:132114847-132114848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34085788 | chr6:132114889-132114890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562947709 | chr6:132114918-132114919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75668960 | chr6:132114935-132114936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75167737 | chr6:132114944-132114945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs376567246 | chr6:132114950-132114951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142177356 | chr6:132114970-132114971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547013287 | chr6:132114973-132114974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57609295 | chr6:132115025-132115026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570117611 | chr6:132115038-132115039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs28464156 | chr6:132115058-132115059 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9493100 | chr6:132115081-132115082 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs569570440 | chr6:132115090-132115091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536525992 | chr6:132115093-132115094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113437082 | chr6:132115102-132115103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555189045 | chr6:132115110-132115111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560803466 | chr6:132115154-132115155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531473572 | chr6:132115196-132115197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185253740 | chr6:132115254-132115255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111709450 | chr6:132115283-132115284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559044640 | chr6:132115287-132115288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72983635 | chr6:132115300-132115301 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:132112600-132114200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr6:132112800-132114200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:132112800-132114200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr6:132112800-132114200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:132113200-132114200 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr6:132113200-132114200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr6:132113200-132114200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr6:132113600-132114400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr6:132114200-132116400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr6:132114200-132116400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr6:132114200-132116400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr6:132114400-132114600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr6:132116400-132116600 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr6:132116400-132117000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr6:132116400-132117000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr6:132116400-132117200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |